Quantum-Si Incorporated (QSI)
NASDAQ:QSI
Want to see QSI full AI Analyst Report?
QSI Stock Chart & Stats
$1.07
-$0.96(-27.61%)
At close: 4:00 PM EST
$1.07
-$0.96(-27.61%)
Day’s Range― - ―
52-Week Range$0.69 - $3.10
Previous CloseN/A
Volume35.47M
Average Volume (3M)6.58M
Market Cap
$230.83M
Enterprise Value$177.20M
Total Cash (Recent Filing)$127.34M
Total Debt (Recent Filing)$3.71M
Price to Earnings (P/E)―
Beta2.94
Next Earnings
Aug 10, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding197,822,660
10 Day Avg. Volume6,140,471
30 Day Avg. Volume6,575,021
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.99
Price to Sales (P/S)89.30
P/FCF Ratio-2.24
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue95.68
Enterprise Value/Gross Profit239.14
Enterprise Value/Ebitda-1.94
Forecast
1Y Price Target
$2.50Price Target Upside133.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.45
Revenue Forecast (FY)$1.03M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthAnalyst highlights a strong balance sheet that provides financial flexibility to fund Proteus development and support a commercial launch.
Commercialization StrategyAnalyst notes management is prioritizing commercialization of the Proteus platform over legacy Platinum sales, which could shift revenue mix toward higher-growth products as market adoption grows.
High-value Product ApplicationsAnalyst believes Proteus capabilities could enable high-value use cases such as detailed protein modification analysis and sequencing of antibody variable regions, positioning the platform for premium market opportunities.
Bears Say
Financial Performance WeaknessCompany results came in below expectations with weaker revenue and declining gross margin, underscoring near-term profitability challenges.
Go-to-market And Near-term Revenue VisibilityCompany's shift to prioritize Proteus adoption over instrument placements implies near-term revenue may be modest and more dependent on consumables than new system sales.
Revenue Recognition RiskAnalyst notes embedded upgrade credits will defer revenue recognition until upgrades occur, creating a potential backlog of unrecognized sales and earnings pressure.
Quantum-Si News
QSI FAQ
What was Quantum-Si Incorporated’s price range in the past 12 months?
Quantum-Si Incorporated lowest stock price was $0.69 and its highest was $3.10 in the past 12 months.
What is Quantum-Si Incorporated’s market cap?
Quantum-Si Incorporated’s market cap is $230.83M.
When is Quantum-Si Incorporated’s upcoming earnings report date?
Quantum-Si Incorporated’s upcoming earnings report date is Aug 10, 2026 which is in 76 days.
How were Quantum-Si Incorporated’s earnings last quarter?
Quantum-Si Incorporated released its earnings results on May 07, 2026. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.01.
Is Quantum-Si Incorporated overvalued?
According to Wall Street analysts Quantum-Si Incorporated’s price is currently Undervalued.
Does Quantum-Si Incorporated pay dividends?
Quantum-Si Incorporated does not currently pay dividends.
What is Quantum-Si Incorporated’s EPS estimate?
Quantum-Si Incorporated’s EPS estimate is -0.11.
How many shares outstanding does Quantum-Si Incorporated have?
Quantum-Si Incorporated has 197,822,660 shares outstanding.
What happened to Quantum-Si Incorporated’s price movement after its last earnings report?
Quantum-Si Incorporated reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went down -7.551%.
Which hedge fund is a major shareholder of Quantum-Si Incorporated?
Currently, no hedge funds are holding shares in QSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum-Si Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.50 (133.64% Upside)
$2.50 (133.64% Upside)
Hedge Fund Trend
Decreased
By 144.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $263.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.08%
12-Months-Change
Fundamentals
Return on Equity
-47.35%
Trailing 12-Months
Asset Growth
-21.34%
Trailing 12-Months
Company Description
Quantum-Si Incorporated
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
QSI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized materially de-risking technical progress for the Proteus platform (successful integrated sequencing, increased amino acid detection, doubled read lengths, PTM strategy) and showed strong early customer engagement and a solid cash runway (~$190M) that supports development through launch. However, near-term revenue remains very small ($258k Q1; ~ $1M outlook for 2026), and the company faces significant R&D/commercialization spend and execution required to scale manufacturing and convert interest into sales. On balance, the advances on Proteus and financial runway are compelling positives, while near-term commercial and burn risks merit monitoring.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.50
▲(133.64% Upside)
Technical Analysis
Ownership Overview
22.76% Insiders
6.80% Mutual Funds
9.27% Other Institutional Investors
49.11% Public Companies and
Individual Investors